Literature DB >> 20977461

Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.

N Kabli1, N Martin, T Fan, T Nguyen, A Hasbi, G Balboni, B F O'Dowd, S R George.   

Abstract

BACKGROUND AND
PURPOSE: µ- and δ-opioid receptors form heteromeric complexes with unique ligand binding and G protein-coupling profiles linked to G protein α z-subunit (Gα(z) ) activation. However, the mechanism of action of agonists and their regulation of the µ-δ receptor heteromer are not well understood. EXPERIMENTAL APPROACH: Competition radioligand binding, cell surface receptor internalization in intact cells, confocal microscopy and receptor immunofluorescence techniques were employed to study the regulation of the µ-δ receptor heteromer in heterologous cells with and without agonist exposure. KEY
RESULTS: Gα(z) enhanced affinity of some agonists at µ-δ receptor heteromers, independent of agonist chemical structure. δ-Opioid agonists displaced µ-agonist binding with high affinity from µ-δ heteromers, but not µ receptor homomers, suggestive of δ-agonists occupying a novel µ-receptor ligand binding pocket within the heteromers. Also, δ-agonists induced internalization of µ-opioid receptors in cells co-expressing µ- and δ-receptors, but not those expressing µ-receptors alone, indicative of µ-δ heteromer internalization. This dose-dependent, Pertussis toxin-resistant and clathrin- and dynamin-dependent effect required agonist occupancy of both µ- and δ-opioid receptors. In contrast to µ-receptor homomers, agonist-induced internalization of µ-δ heteromers persisted following chronic morphine exposure. CONCLUSIONS AND IMPLICATIONS: The µ-δ receptor heteromer may contain a novel δ-agonist-detected, high-affinity, µ-receptor ligand binding pocket and is regulated differently from the µ-receptor homomer following chronic morphine exposure. Occupancy of both µ- and δ-receptor binding pockets is required for δ-agonist-induced endocytosis of µ-δ receptor heteromers. δ-Opioid agonists target µ-δ receptor heteromers, and thus have a broader pharmacological specificity than previously identified.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977461      PMCID: PMC2998692          DOI: 10.1111/j.1476-5381.2010.00944.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Opioid receptors.

Authors:  Maria Waldhoer; Selena E Bartlett; Jennifer L Whistler
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

2.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

Authors:  Ivone Gomes; Achla Gupta; Julija Filipovska; Hazel H Szeto; John E Pintar; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

3.  Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice.

Authors:  K Gulya; M Kriván; N Nyolczas; Z Sarnyai; G L Kovács
Journal:  Eur J Pharmacol       Date:  1988-06-10       Impact factor: 4.432

4.  The G alpha z gene product in human erythrocytes. Identification as a 41-kilodalton protein.

Authors:  R T Premont; A Buku; R Iyengar
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

5.  G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons.

Authors:  G G Holz; R M Kream; A Spiegel; K Dunlap
Journal:  J Neurosci       Date:  1989-02       Impact factor: 6.167

6.  Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist.

Authors:  P S Portoghese; M Sultana; A E Takemori
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

7.  Identification of a GTP-binding protein alpha subunit that lacks an apparent ADP-ribosylation site for pertussis toxin.

Authors:  H K Fong; K K Yoshimoto; P Eversole-Cire; M I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle.

Authors:  A DeLean; R J Lefkowitz
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

9.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

Authors:  B L Kieffer; K Befort; C Gaveriaux-Ruff; C G Hirth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Allosteric coupling between morphine and enkephalin receptors in vitro.

Authors:  R B Rothman; T C Westfall
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

View more
  28 in total

Review 1.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors.

Authors:  Matthew D Metcalf; Ajay S Yekkirala; Michael D Powers; Kelley F Kitto; Carolyn A Fairbanks; George L Wilcox; Philip S Portoghese
Journal:  ACS Chem Neurosci       Date:  2012-05-22       Impact factor: 4.418

Review 4.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

Review 5.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 6.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

Review 7.  Opioid receptor trafficking and interaction in nociceptors.

Authors:  X Zhang; L Bao; S Li
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 8.  Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 9.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 10.  In vivo opioid receptor heteromerization: where do we stand?

Authors:  D Massotte
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.